Moreover, the hepatic contents of MDA, a byproduct resulting from lipid peroxidation, were noticeably increased in the AF-treated Akr1a1−/− group but remained low in the other groups (Fig. 3F). This evidence concerns the gene AKR1A1 and atrial fibrillation.